Changes in Cardiac and Vascular Haemodynamics As Potential Mediators of Improvements in Cardiovascular and Kidney Outcomes with Empagliflozin in Type 2 Diabetes.
JOURNAL OF DIABETES AND ITS COMPLICATIONS（2023）
Key words
Blood pressure,Cardiovascular disease,Empagliflozin,Haemodynamic,Mediation analysis,Sodium glucose cotransporter,Type 2 diabetes
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined